Cvs Health (CVS) Receivables (2009 - 2026)

Cvs Health's Receivables history runs 18 years deep, the most recent figure standing at $53.5 billion for Q1 2026.

• Quarterly Receivables rose 6.85% year-over-year to $53.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.5 billion (up 6.85% YoY) and the FY2025 annual result came in at $47.7 billion, up 2.87% from the prior year.
• Receivables was $53.5 billion for Q1 2026 at Cvs Health, up from $47.7 billion in the prior quarter.
• Across five years, Receivables topped out at $55.1 billion in Q3 2025 and bottomed at $14.6 billion in Q4 2024.
• A 5-year average of $41.9 billion and a median of $42.8 billion in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables jumped 246.35% — and 2024, when it plunged 69.0%.
• Cvs Health's Receivables stood at $36.3 billion in 2022, then climbed by 30.0% to $47.1 billion in 2023, then plunged by 69.0% to $14.6 billion in 2024, then soared by 226.29% to $47.7 billion in 2025, then increased by 12.22% to $53.5 billion in 2026.
• Business Quant data shows CVS's Receivables at $53.5 billion in Q1 2026, $47.7 billion in Q4 2025, and $55.1 billion in Q3 2025.